# ABCD2

## Overview
The ABCD2 gene encodes the ATP-binding cassette subfamily D member 2 protein, a peroxisomal transporter involved in lipid metabolism. This protein is classified as a half-transporter, featuring one transmembrane domain and one nucleotide-binding domain, which are essential for its function in transporting very long-chain fatty acids (VLCFAs) and polyunsaturated fatty acids (PUFAs) across the peroxisomal membrane (Morita2012Peroxisomal). ABCD2 plays a significant role in fatty acid homeostasis and energy metabolism, contributing to neuronal function and membrane phospholipid structure (Fourcade2009A). It is highly expressed in tissues such as the brain and spinal cord, where it supports the oxidation of VLCFAs and PUFAs (Fourcade2009A). The protein's ability to form homodimers and heterodimers with other ABCD proteins, such as ABCD1, is crucial for its transport function (Geillon2014StructureFunction). ABCD2's potential to compensate for ABCD1 deficiency highlights its therapeutic relevance in disorders like X-linked adrenoleukodystrophy (X-ALD) (Genin2009Induction).

## Structure
The ABCD2 protein is a peroxisomal ATP-binding cassette (ABC) transporter, classified as a half-transporter with one transmembrane domain (TMD) and one nucleotide-binding domain (NBD) (Morita2012Peroxisomal). The primary structure of ABCD2 includes conserved motifs such as Walker A and Walker B, and an ABC signature sequence within the NBD (Morita2012Peroxisomal). The secondary structure is predicted to have a hydrophobic amino-terminal half with six transmembrane segments and a hydrophilic COOH-terminal half containing the NBD (Morita2012Peroxisomal). 

The tertiary structure involves the folding of these domains into a functional transporter, although specific details are not provided in the context. The quaternary structure of ABCD2 involves dimerization, which is necessary for its function as a transporter. ABCD2 can form both homodimers and heterodimers with other ABCD proteins, such as ABCD1, to transport very long-chain fatty acids (VLCFA) and polyunsaturated fatty acids (Morita2012Peroxisomal; Geillon2014StructureFunction). The protein's ability to dimerize is crucial for its transport function, as ATP binding requires the cooperation of two NBDs (Geillon2014StructureFunction).

## Function
The ABCD2 gene encodes a peroxisomal transporter protein that plays a crucial role in fatty acid metabolism and homeostasis. This protein is involved in the degradation of very long-chain fatty acids (VLCFAs) and monounsaturated fatty acids (MUFAs), as well as in the synthesis of polyunsaturated fatty acids (PUFAs) like docosahexaenoic acid (DHA) and docosapentaenoic acid (DPA) (Fourcade2009A). ABCD2 is primarily active in the peroxisomal membrane, where it facilitates the import of VLCFA CoA esters into the peroxisome for β-oxidation, a critical process for preventing the accumulation of VLCFAs (Genin2009Induction).

In healthy cells, ABCD2 is highly expressed in tissues such as the brain, adrenal gland, spinal cord, and sciatic nerve, where it supports the oxidation of VLCFAs and PUFAs, contributing to neuronal function and membrane phospholipid structure (Fourcade2009A). The protein's activity is particularly significant in maintaining fatty acid balance and energy metabolism, which are essential for cellular homeostasis and preventing neurodegenerative diseases (Fourcade2009A). ABCD2 can also compensate for ABCD1 deficiency, highlighting its potential as a therapeutic target in disorders like X-linked adrenoleukodystrophy (X-ALD) (Genin2009Induction).

## Clinical Significance
Mutations or alterations in the expression of the ABCD2 gene have been studied in the context of X-linked adrenoleukodystrophy (X-ALD), a neurodegenerative disorder primarily associated with mutations in the ABCD1 gene. ABCD2, a close homolog of ABCD1, can partially compensate for ABCD1 deficiencies. Overexpression of ABCD2 has been shown to prevent the accumulation of very-long-chain fatty acids (VLCFAs) and the onset of neurological symptoms in Abcd1 knockout mice, suggesting its potential as a therapeutic target (Pujol2004Functional; Singh2009Silencing).

Inactivation of the ABCD2 gene in mice leads to late-onset ataxia, characterized by mitochondrial, Golgi, and endoplasmic reticulum damage, as well as neuronal and axonal degeneration. This condition mimics symptoms observed in Friedreich ataxia or vitamin E deficiency, including defective spinal reflexes and an ataxic phenotype (Ferrer2005Inactivation). Despite the functional redundancy between ABCD1 and ABCD2, ABCD2-deficient mice exhibit unique abnormalities, such as hyperactivity and lack of habituation, not seen in ABCD1-mutant mice (Ferrer2005Inactivation).

No human syndrome has been directly linked to the ABCD2 locus, but the mouse phenotype may help identify similar human conditions, such as autosomal recessive peripheral neuropathy with cerebellar involvement (Ferrer2005Inactivation).

## Interactions
ABCD2 is involved in several interactions with other proteins, particularly in the context of lipid metabolism. The ABCD2 protein has been shown to potentially interact with ACSL4, a gene involved in fatty acid metabolism. This interaction was suggested by experiments where cell lysates were pulled down with an ABCD2-specific antibody and immunoblotted with an ACSL4-specific antibody, indicating a possible protein-protein interaction (Park2018Suppression).

In terms of transcriptional regulation, ABCD2 expression is modulated by thyroid hormone receptors TRα and TRβ, which interact with sterol regulatory element-binding protein 1 (SREBP1) at the ABCD2 promoter. TRα and TRβ can co-stimulate SREBP1-mediated ABCD2 expression, with TRα enhancing and TRβ repressing this expression in a ligand-dependent manner. These interactions occur at the SRE/DR-4 element of the ABCD2 promoter, where SREBP1 and TRs need to bind concurrently for activation (Weinhofer2008Distinct).

ABCD2 also plays a role in the degradation of very long-chain fatty acids (VLCFAs) and may form functional complexes with other peroxisomal ABC transporters, such as ABCD1, to facilitate this process (Fourcade2009A).


## References


[1. (Ferrer2005Inactivation) Isidre Ferrer, Josef P. Kapfhammer, Colette Hindelang, Stephan Kemp, Nathalie Troffer-Charlier, Vania Broccoli, Noëlle Callyzot, Petra Mooyer, Jacqueline Selhorst, Peter Vreken, Ronald J.A. Wanders, Jean Louis Mandel, and Aurora Pujol. Inactivation of the peroxisomal abcd2 transporter in the mouse leads to late-onset ataxia involving mitochondria, golgi and endoplasmic reticulum damage. Human Molecular Genetics, 14(23):3565–3577, October 2005. URL: http://dx.doi.org/10.1093/hmg/ddi384, doi:10.1093/hmg/ddi384. This article has 84 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddi384)

[2. (Genin2009Induction) Emmanuelle C. Genin, Catherine Gondcaille, Doriane Trompier, and Stéphane Savary. Induction of the adrenoleukodystrophy-related gene (abcd2) by thyromimetics. The Journal of Steroid Biochemistry and Molecular Biology, 116(1–2):37–43, August 2009. URL: http://dx.doi.org/10.1016/j.jsbmb.2009.04.006, doi:10.1016/j.jsbmb.2009.04.006. This article has 29 citations.](https://doi.org/10.1016/j.jsbmb.2009.04.006)

[3. (Morita2012Peroxisomal) Masashi Morita and Tsuneo Imanaka. Peroxisomal abc transporters: structure, function and role in disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1822(9):1387–1396, September 2012. URL: http://dx.doi.org/10.1016/j.bbadis.2012.02.009, doi:10.1016/j.bbadis.2012.02.009. This article has 134 citations.](https://doi.org/10.1016/j.bbadis.2012.02.009)

[4. (Pujol2004Functional) Aurora Pujol, Isidre Ferrer, Carme Camps, Elisabeth Metzger, Colette Hindelang, Noëlle Callizot, Montse Ruiz, Teresa Pàmpols, Marisa Giròs, and Jean Louis Mandel. Functional overlap between abcd1 (ald) and abcd2 (aldr) transporters: a therapeutic target for x-adrenoleukodystrophy. Human Molecular Genetics, 13(23):2997–3006, October 2004. URL: http://dx.doi.org/10.1093/hmg/ddh323, doi:10.1093/hmg/ddh323. This article has 158 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddh323)

[5. (Fourcade2009A) Stéphane Fourcade, Montserrat Ruiz, Carme Camps, Agatha Schlüter, Sander M. Houten, Petra A. W. Mooyer, Teresa Pàmpols, Georges Dacremont, Ronald J. A. Wanders, Marisa Giròs, and Aurora Pujol. A key role for the peroxisomalabcd2transporter in fatty acid homeostasis. American Journal of Physiology-Endocrinology and Metabolism, 296(1):E211–E221, January 2009. URL: http://dx.doi.org/10.1152/ajpendo.90736.2008, doi:10.1152/ajpendo.90736.2008. This article has 81 citations.](https://doi.org/10.1152/ajpendo.90736.2008)

[6. (Singh2009Silencing) Jaspreet Singh, Mushfiquddin Khan, and Inderjit Singh. Silencing of abcd1 and abcd2 genes sensitizes astrocytes for inflammation: implication for x-adrenoleukodystrophy. Journal of Lipid Research, 50(1):135–147, January 2009. URL: http://dx.doi.org/10.1194/jlr.m800321-jlr200, doi:10.1194/jlr.m800321-jlr200. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.1194/jlr.m800321-jlr200)

[7. (Park2018Suppression) Sujeong Park, Jinjoo Oh, Yong‐Il Kim, Seong‐Kyu Choe, Churl‐Hong Chun, and Eun‐Jung Jin. Suppression of <scp>abcd2</scp> dysregulates lipid metabolism via dysregulation of <scp>mir‐141:acsl4</scp> in human osteoarthritis. Cell Biochemistry and Function, 36(7):366–376, September 2018. URL: http://dx.doi.org/10.1002/cbf.3356, doi:10.1002/cbf.3356. This article has 12 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cbf.3356)

[8. (Geillon2014StructureFunction) Flore Geillon, Catherine Gondcaille, Soëli Charbonnier, Carlo W. Van Roermund, Tatiana E. Lopez, Alexandre M.M. Dias, Jean-Paul Pais de Barros, Christine Arnould, Ronald J. Wanders, Doriane Trompier, and Stéphane Savary. Structure-function analysis of peroxisomal atp-binding cassette transporters using chimeric dimers. Journal of Biological Chemistry, 289(35):24511–24520, August 2014. URL: http://dx.doi.org/10.1074/jbc.m114.575506, doi:10.1074/jbc.m114.575506. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m114.575506)

[9. (Weinhofer2008Distinct) Isabelle Weinhofer, Markus Kunze, Heidelinde Rampler, Sonja Forss-Petter, Jacques Samarut, Michelina Plateroti, and Johannes Berger. Distinct modulatory roles for thyroid hormone receptors trα and trβ in srebp1-activated abcd2 expression. European Journal of Cell Biology, 87(12):933–945, December 2008. URL: http://dx.doi.org/10.1016/j.ejcb.2008.08.002, doi:10.1016/j.ejcb.2008.08.002. This article has 20 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.ejcb.2008.08.002)